Sales of Rx/reimbursement adult incontinence struggled in sales over the review period in Germany due to social considerations, however 2020 bucked the trend due to the pandemic. Economic uncertainties coupled with more conservative behaviour of the older populace translated into various attempts to save, including the purchase of adult incontinence products. A proportion of consumers switched to purchasing from the Rx/reimbursement route rather than in retail in an attempt to be more frugal wit...

Euromonitor International’s Rx/Reimbursement Adult Incontinence in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2025 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Rx/Reimbursement Adult Incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.